Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBenha University

About this trial

This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.

Eligibility criteria

Qualifiers

None

Disqualifiers

Pregnancy

Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels

Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis

Expected mortality within 48 hours of ICU admission

Trial design

Treatments tested in this trial

  • Capillary Leak Index Versus

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators